ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib-Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency.

Jiali Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.